What is Bicara Therapeutics's operating lease liabilities?

Bicara Therapeutics (BCAX) reported operating lease liabilities of $301K in Q1 2026.

What is the long-term trend for Bicara Therapeutics's operating lease liabilities?

Over 2 years (2023 to 2025), Bicara Therapeutics's operating lease liabilities has grown at a 26.3% compound annual growth rate (CAGR), from $372K to $593K.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Bicara Therapeutics BCAX Operating Lease Liabilities

Operating Lease Liabilities at other companies

ArriVent BioPharma, Inc.AVBP

$320K—

Inhibrx Biosciences, Inc.INBX

$3.5M-40.8%

ImmunomeIMNM

$3.69M-22.6%

Nuvation BioNUVB

$2.2M-42.7%

Summit TherapeuticsSMMT

$16.86M+480%

Erasca, Inc.ERAS

$40.7M-11.6%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's operating lease liabilities?: Bicara Therapeutics (BCAX) reported operating lease liabilities of $301K in Q1 2026.
What is the long-term trend for Bicara Therapeutics's operating lease liabilities?: Over 2 years (2023 to 2025), Bicara Therapeutics's operating lease liabilities has grown at a 26.3% compound annual growth rate (CAGR), from $372K to $593K.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.